These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 1001603

  • 1. [After miniaturization to the limit, a double phase estro-progestin with early reinforcement. Result of a study of a new contraceptive based on d-norgestrel].
    Soutoul JH, Renaud M, Bertrand J.
    Gynecologie; 1976; 27(5):487-93. PubMed ID: 1001603
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Progestational potency of oral contraceptives.
    Dickey RP, Stone SC.
    Obstet Gynecol; 1976 Jan; 47(1):106-12. PubMed ID: 1246375
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
    Jespersen J, Kluft C.
    Scand J Clin Lab Invest; 1982 Nov; 42(7):563-6. PubMed ID: 6818678
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Incidence of hyperprolactinemia during oral contraceptive therapy.
    Reyniak JV, Wenof M, Aubert JM, Stangel JJ.
    Obstet Gynecol; 1980 Jan; 55(1):8-11. PubMed ID: 7352067
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Oral-cytological studies on the effect of combined contraceptive preparations as compared to menstruation and pregnancy].
    Zellner P, Klinger G.
    Stomatol DDR; 1982 Oct; 32(10):673-7. PubMed ID: 6190274
    [No Abstract] [Full Text] [Related]

  • 10. Central and peripheral parameters of the menstrual cycle under the influence of a new combined oral contraceptive.
    Spona J, Schneider WH.
    Acta Obstet Gynecol Scand Suppl; 1976 Oct; 54():45-50. PubMed ID: 788444
    [No Abstract] [Full Text] [Related]

  • 11. [Some effects of hormonal contraceptives on the mammary tissue. Influence of duration of use and age os user].
    de Sampaio Junior LF, Stecca J, Neme B.
    Matern Infanc (Sao Paulo); 1974 Oct; 33(4):509-30. PubMed ID: 4470961
    [No Abstract] [Full Text] [Related]

  • 12. Norgestimate: overview of a monophasic formulation.
    Anderson FD, Gillmer MD.
    Int J Fertil Menopausal Stud; 1993 Oct; 38 Suppl 3():126-32. PubMed ID: 8260971
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of oral contraceptives on vitamin B6 nutriture of young women.
    Vir SC, Love AH.
    Int J Vitam Nutr Res; 1980 Oct; 50(1):29-34. PubMed ID: 7390712
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Elevation of serum prolactin during application of oral contraceptives.
    Dericks-Tan JS, Taubert HD.
    Contraception; 1976 Jul; 14(1):1-8. PubMed ID: 975808
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
    Schneider WH, Schmid R, Spona J.
    Wien Klin Wochenschr; 1981 Oct 16; 93(19):601-4. PubMed ID: 6798765
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.